Literature DB >> 31473295

Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial.

Paulo Müller Ramos1, Rodney D Sinclair2, Michal Kasprzak3, Hélio Amante Miot4.   

Abstract

Entities:  

Year:  2019        PMID： 31473295     DOI： 10.1016/j.jaad.2019.08.060

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  10 in total

1.  Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women.

Authors:  Rita Rodrigues-Barata; Oscar M Moreno-Arrones; David Saceda-Corralo; Juan Jiménez-Cauhé; Daniel Ortega-Quijano; Diego Fernández-Nieto; Pedro Jaén-Olasolo; Sergio Vaño-Galvan
Journal:  Skin Appendage Disord       Date:  2020-02-21

2.  Oral minoxidil use in androgenetic alopecia and telogen effluvium.

Authors:  Brittany Feaster; Toluwalashe Onamusi; Jerry E Cooley; Amy J McMichael
Journal:  Arch Dermatol Res       Date:  2022-03-04       Impact factor: 3.017

3.  Development and Validation of a Dermoscopic Severity Score for Female Pattern Hair Loss.

Authors:  Mariana Álvares Penha; Paulo Müller Ramos; Vinícius de Souza; Helio Amante Miot
Journal:  Skin Appendage Disord       Date:  2021-12-14

Review 4.  Pharmacological Management of Pattern Hair Loss.

Authors:  Sandeep Suresh Sattur; Indu Sandeep Sattur
Journal:  Indian J Plast Surg       Date:  2021-12-13

Review 5.  Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.

Authors:  Mark S Nestor; Glynis Ablon; Anita Gade; Haowei Han; Daniel L Fischer
Journal:  J Cosmet Dermatol       Date:  2021-11-06       Impact factor: 2.189

Review 6.  Advances in hair growth.

Authors:  Dmitri Wall; Nekma Meah; Nicole Fagan; Katherine York; Rodney Sinclair
Journal:  Fac Rev       Date:  2022-01-12

7.  There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses.

Authors:  Aditya K Gupta; Deanna C Hall; Mesbah Talukder; Mary A Bamimore
Journal:  Skin Appendage Disord       Date:  2022-06-30

Review 8.  Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review.

Authors:  Kornelia Pietrauszka; Beata Bergler-Czop
Journal:  Postepy Dermatol Alergol       Date:  2020-10-16       Impact factor: 1.664

9.  Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial.

Authors:  Xuelei Liang; Yuan Chang; Haixuan Wu; Yi Liu; Jian Zhao; Leyi Wang; Fenglin Zhuo
Journal:  Front Med (Lausanne)       Date:  2022-07-11

Review 10.  Measuring Patient Quality of Life Following Treatment for Alopecia.

Authors:  Kunlawat Thadanipon; Poonkiat Suchonwanit
Journal:  Patient Prefer Adherence       Date:  2021-07-16       Impact factor: 2.711
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.